Gold neurotoxicity and myokymia
Caldron, P.H.; Wilbourn, A.J.
Journal of Rheumatology 15(3): 528-529
1988
ISSN/ISBN: 0315-162X PMID: 3379631 Document Number: 319226
Document emailed within 1 workday
Related Documents
Hill, D.T.; Sutton, B.M.; Isab, A.A.; Razi, T.; Sadler, P.J.; Trooster, J.M.; Calis, G.H.M. 1983: Gold-195 Mössbauer studies of some gold(I) thiolates and their phosphine complexes including certain antiarthritic gold drugs Inorganic Chemistry 22(20): 2936-2942Palmer, D.G.; Dunckley, J.V. 1973: Gold levels in serum during the treatment of rheumatoid arthritis with gold sodium thiomalate Australian and New Zealand Journal of Medicine 3(5): 461-466
Terribile Wiel Marin, T.; Mayellaro, F. 1986: Presence of gold in the oral mucosa of wearers of gold alloy prostheses Agressologie 27(1): 49-51
Nordberg, M. 1995: Going for the gold. EMS Gold Standard Service Award. Margate Fire Rescue, FL Emergency Medical Services 24(7): 28-30
Wesołowski, S.; Boros, P.; Franczuk, M. 2002: Gold strategy, early detection of COPD and need for "gold" standard of spirometry Pneumonologia i Alergologia Polska 70(9-10): 439-443
Mancel, E.; Janin, A.; Duquesnoy, B.; Noachovitch-Rigaut, B.; Hatron, P.Y.; Constantinides, G. 1992: Gold salt deposits in the conjunctiva in rheumatoid arthritis after gold therapy. a systematic study of 15 biopsies Revue du Rhumatisme et des Maladies Osteo-Articulaires 59(11): 715-720
Lakshmi, V.Jhansi.; Kannan, K.P. 2016: Isolation and identification of gold nanoparticles synthesizing fungi from Indian Kolar Gold Field mine soil Journal of Environmental Biology 37(4): 565-571
Bando, M.; Takishita, Y.; Bando, H.; Hashimoto, Y.; Sano, T. 1992: A case of gold-induced pneumonitis showing a positive reaction in the drug lymphocyte stimulation test (DLST) for gold Nihon Kyobu Shikkan Gakkai Zasshi 30(1): 128-132
Shahar, E.; Shapiro, M.S. 1988: Myokymia: a rare manifestation of thyrotoxicosis Harefuah 115(3-4): 69-70
Neetens, A.; Martin, J.J. 1982: Superior oblique myokymia in a case of adrenoleucodystrophy Bulletin de la Societe Belge d'Ophtalmologie 203: 129-134
Thurston, S.E.; Saul, R.F. 1991: Superior oblique myokymia: quantitative description of the eye movement Neurology 41(10): 1679-1681
Braune, H.J.; Huffmann, G. 1990: So-called superior oblique muscle myokymia from the neurologic viewpoint Der Nervenarzt 61(6): 369-371
Kaufman, L.D.; Kaufman, M.A.; Krupp, L.B. 1995: Movement disorders in the eosinophilia-myalgia syndrome: tremor, myoclonus, and myokymia Journal of Rheumatology 22(1): 157-160
Chakravarty, A.; Ghosh, B.; Sengupta, S.; Mukhopadhyay, S. 2003: X-linked Charcot-Marie-Tooth disease with myokymia: report of a family Neurology India 51(3): 385-387
Gold, R.; Kappos, L. 1991: Facial myokymia caused by pontine lesions and central fever in multiple sclerosis--case report Schweizerische Rundschau für Medizin Praxis 80(47): 1327-1329
Harayama, H.; Shirakawa, K.; Yuasa, T.; Fukuhara, N.; Tsubaki, T. 1980: Clinical and electrophysiological studies on a case of myokymia evidence suggesting the hyperexcitability of the proximal alpha motor fibers Rinsho Shinkeigaku 20(5): 346-353
Ema, M.; Fukui, Y.; Aoyama, H.; Fujiwara, M.; Fuji, J.; Inouye, M.; Iwase, T.; Kihara, T.; Oi, A.; Otani, H.; Shinomiya, M.; Sugioka, K.; Yamano, T.; Yamashita, K.H.; Tanimura, T. 2007: Comments from the Developmental Neurotoxicology Committee of the Japanese Teratology Society on the OECD Guideline for the Testing of Chemicals, Proposal for a New Guideline 426, Developmental Neurotoxicity Study, Draft Document (October 2006 version), and on the Draft Document of the Retrospective Performance Assessment of the Draft Test Guideline 426 on Developmental Neurotoxicity Congenital anomalies 47(2): 74-76
Merchut, M.P.; Biller, J.; Brumlik, J.; Azar-Kia, B.; Russell, E.J. 1985: Isolated facial myokymia and facial contracture: computed tomography and magnetic resonance imaging correlation Journal of Clinical Neuro-Ophthalmology 5(2): 120-123
Hutchinson, B.R. 2003: Lignocaine neurotoxicity New Zealand Medical Journal 116(1178): U525
Blundell, J.E. 1992: Dexfenfluramine and neurotoxicity Lancet 339(8789): 359-60; Author Reply 360-1